Hormone Replacement Therapy News and Research

RSS

Hormone Replacement Therapy (HRT) sometimes called estrogent replacement therapy or ERT, refers to a woman taking supplements of hormones such as estrogen alone or estrogen with another hormone called progesterone (progestin in its synthetic form). HRT replaces hormones that a woman’s body should be making or used to make.

HRT safe for healthy women entering menopause

HRT in the early postmenopausal period is safe, and healthy women going through the first few years of the menopause who need HRT to relieve symptoms should have no fears about its use. This is the conclusion and clinical advice of the First Global Summit on Menopause-Related Issues, which was held in Zurich on March 29th and 30th, 2008.

20 May 2008

Laser eye surgery comes under close scrutiny

More and more people are having laser vision corrective surgery (LASIK surgery) in the hope that their vision will be restored to such an extent that glasses will no longer be needed.

28 Apr 2008

Coffee protects some women against breast cancer

Depending on which variant of a certain gene a woman has, a coffee consumption rate of at least two-three cups a day can either reduce the total risk of developing breast cancer or delay the onset of cancer. This is shown in new research from Lund University and Malmo University in Sweden.

24 Apr 2008

Vitamin D protects women from breast cancer

The connection between vitamin D levels and certain forms of cancer has been suspected for some time but now German researchers have come up with clear proof of the link.

21 Apr 2008

Acupuncture provides effective relief from hot flushes for women taking tamoxifen after surgery for breast cancer

Acupuncture provides effective relief from hot flushes in women who are being treated with the anti-oestrogen tamoxifen following surgery for breast cancer, according to new research presented today (Friday) at the 6th European Breast Cancer Conference (EBCC-6) in Berlin.

18 Apr 2008

What we eat and drink affects our risk of cancer

A healthy diet and lifestyle protect against a wide range of diseases, and new research presented at the American Association for Cancer Research 2008 Annual Meeting, April 12-16, shows that cancer is no exception.

13 Apr 2008

Synthetic progestin linked to breast cancer

Millions of post-menopausal women use hormone replacement therapy (HRT) as a method to reduce symptoms associated with menopause.

2 Apr 2008

HRT increases breast cancer recurrence

Hormone replacement therapy (HRT) for peri- and postmenopausal symptoms increases disease recurrence in breast cancer survivors, according to an article published online March 25 in the Journal of the National Cancer Institute .

26 Mar 2008

HRT users and non-HRT users benefited equally from the exercise

Aerobic exercise significantly decreased the chemical imbalances that can lead to heart disease and stroke in postmenopausal women according to a study in the spring issue of the Journal of Women and Aging.

19 Mar 2008

Is deep-vein thrombosis lurking in your legs?

They kill 300,000 people a year - but most of them could be prevented. They strike more than a million people every year, most of them out of the blue - and half without causing symptoms.

14 Mar 2008

Long-term effects of synthetic progestins cause for concern

The widely used synthetic progestin medroxyprogesterone acetate (MPA) decreased endothelial function in premenopausal women in a study done at the University of Oregon.

11 Mar 2008

Cancer risk from HRT remains long after treatment has stopped

The results of a new study have shown that the risk of cancer associated with Hormone Replacement Therapy (HRT) continues long after a woman stops taking it.

5 Mar 2008

HRT appears to have no effect on risk and severity of rheumatoid arthritis

Although rheumatoid arthritis (RA) is more predominant in women, the reasons for this are unclear.

28 Feb 2008

Annual cancer statistics show substantial declines in mortality rates

The American Cancer Society's annual cancer statistics report finds that death rates from cancer in the United States have decreased by 18.4 percent among men and by 10.5 percent among women since mortality rates began to decline in the early 1990s, which translates to the avoidance of more than half a million cancer deaths (534,500) in the United States.

21 Feb 2008

Gene expression in meningiomas may vary by hormone receptor status

An association between hormones and meningioma has long been postulated, but the specific nature of this relationship has remained unclear.

4 Feb 2008

New research advancements in the treatment of premature ovarian failure

Scientific Director of the Meharry Center for Women's Health Research and a team of researchers from the University of Texas Medical Branch and the University of Saskatchewan have recently discovered that the gene mutation believed to be a possible cause of premature ovarian failure may be corrected when an adenovirus compensating for the mutated gene is introduced. Findings were reported in the recent issue of Molecular Human Reproduction.

15 Jan 2008

The link between combined HRT use and the risk of lobular breast cancers

Postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new findings by researchers at Fred Hutchinson Cancer Research Center.

15 Jan 2008

Bio-identical hormone replacement therapies targeted by FDA

The U.S. Food and Drug Administration (FDA) sent letters warning seven pharmacy operations that the claims they make about the safety and effectiveness of their so-called "bio-identical hormone replacement therapy," or "BHRT" products are unsupported by medical evidence, and are considered false and misleading by the agency.

10 Jan 2008

FDA says claims about benefits of bio-identical hormone replacement therapy are false and misleading

Health officials in the United States have issued a warning regarding so-called "bio-identical" hormone therapy (BHRT).

10 Jan 2008

No excess cardiovascular risk from HRT for most patients

An American Association of Clinical Endocrinologists (AACE) analysis of several studies monitoring the impact of Hormone Replacement Therapy (HRT) shows young women in early menopause may not only have no increased cardiovascular risk from the therapy, but may indeed show benefit in the future.

3 Jan 2008